Ruane, Cunniff & Goldfarb’s CVS Health CVS Stock Holding History

Ruane, Cunniff & Goldfarb’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-12,701	Closed	-$997K	–	76
2017 Q1	$997K	Sell	12,701 -700	-5%	-$55.9K	0.01%	69
2016 Q4	$1.06M	Sell	13,401 -400	-3%	-$32.4K	0.01%	73
2016 Q3	$1.23M	Sell	13,801 -1,055	-7%	-$99.6K	0.01%	76
2016 Q2	$1.42M	Sell	14,856 -1,125	-7%	-$112K	0.01%	80
2016 Q1	$1.66M	Sell	15,981 -2,172	-12%	-$211K	0.01%	92
2015 Q4	$1.77M	Sell	18,153 -6,800	-27%	-$666K	0.01%	90
2015 Q3	$2.41M	Hold	24,953	–	–	0.01%	89
2015 Q2	$2.62M	Hold	24,953	–	–	0.01%	89
2015 Q1	$2.58M	Hold	24,953	–	–	0.01%	88
2014 Q4	$2.4M	Sell	24,953 -1,600	-6%	-$141K	0.01%	91
2014 Q3	$2.11M	Sell	26,553 -475	-2%	-$37.4K	0.01%	93
2014 Q2	$2.04M	Sell	27,028 -21	-0.1%	-$1.59K	0.01%	93
2014 Q1	$2.02M	Buy	27,049 +1,595	+6%	+$113K	0.01%	88
2013 Q4	$1.82M	Sell	25,454 -475	-2%	-$30.5K	0.01%	94
2013 Q3	$1.47M	Buy	25,929 +1,774	+7%	+$106K	0.01%	99
2013 Q2	$1.38M	Buy	+24,155	New	+$1.4M	0.01%	92

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Ruane, Cunniff & Goldfarb's CVS Position: Q2 2017 in Review

Ruane, Cunniff & Goldfarb sold out of CVS Health (CVS) in Q2 2017, closing a stake of 12,701 shares — an estimated $997K sold.

Ruane, Cunniff & Goldfarb first reported a position in CVS in Q2 2013 and held it in 16 quarters. The position peaked at $2.62M in Q2 2015. 1,552 funds tracked by Wall St. Rank hold CVS as of Q2 2017.

Ruane, Cunniff & Goldfarb reported no remaining CVS Health position as of Q2 2017 after selling out during the quarter.
Ruane, Cunniff & Goldfarb sold 12,701 CVS Health shares in Q2 2017, an estimated $997K.
Ruane, Cunniff & Goldfarb first reported a position in CVS Health in Q2 2013 and held it in 16 quarters.
Ruane, Cunniff & Goldfarb's CVS Health position peaked at $2.62M in Q2 2015.
1,552 funds tracked by Wall St. Rank held CVS Health as of Q2 2017.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q2 2017, filed 14 Aug 2017.